Bio-Techne Releases Fourth Quarter Fiscal 2026 Results
Revenue$321.2 million+1% YoY
EPS$0.35
Collected automatically from companies' SEC filings (Form 8-K, Item 2.02)
Forensic equity research on US stocks. No spam, unsubscribe anytime.